Novavax says its Omicron-specific vaccine candidate works as a booster


The findings come within three weeks after Novavax earned two critical green lights from regulators.

Previous Accenture’s Chuck Rozea on Boston’s unique position to help cut the cost of new treatments
Next Here's where Panera Bread has opened its debut 'urban store'